In details, RAS appears to enhance the TME PD-L1 expression, the immunosuppressive phenotype of tumor associated macrophages (TAMs) and myeloid-deprived suppressive cells (MDSCs), mainly through the production of immunosuppressive chemokine [72,73,79]. This evidence concerns the gene CD274 and neoplasm.